Perrigo Company plc Repayments of Long-Term Debt
Perrigo Company plc (PRGO) reported Repayments of Long-Term Debt of $759.30 million for the 6-month period ending 2026-06-27, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebt · last filed 2026-08-05
- Perrigo Company plc repayments of long-term debt for the quarter ending 2026-06-27 was $335.00M, a 3706.82% increase year-over-year.
- Perrigo Company plc repayments of long-term debt for the quarter ending 2026-03-28 was $424.30M, a 4721.59% increase year-over-year.
- Perrigo Company plc repayments of long-term debt for the quarter ending 2025-12-31 was $8.70M, a 99.22% decline year-over-year.
- Perrigo Company plc repayments of long-term debt for the quarter ending 2025-09-27 was $8.50M, a 97.88% decline year-over-year.
- Perrigo Company plc repayments of long-term debt for fiscal 2025 was $34.80M, a 97.72% decline from fiscal 2024.
- Perrigo Company plc repayments of long-term debt for fiscal 2024 was $1.53B, a 370.03% increase from fiscal 2023.
- Perrigo Company plc repayments of long-term debt for fiscal 2023 was $325.30M, a 66.48% decline from fiscal 2022.
- Perrigo Company plc repayments of long-term debt for fiscal 2022 was $970.60M, a 3071.90% increase from fiscal 2021.
| Period end | Repayments of Long-term Debt 3 month | Repayments of Long-term Debt 6 month | Repayments of Long-term Debt 9 month | Repayments of Long-term Debt 9 month as first filed | Repayments of Long-term Debt 12 month | Repayments of Long-term Debt 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-27 | $335.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $759.30M 10-Q · filed 2026-08-05 | $768.00M derived: sum of 3 quarters · filed 2026-08-05 | $776.50M derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2026-03-28 | $424.30M 10-Q · filed 2026-05-06 | $433.00M derived: sum of 2 quarters · filed 2026-05-06 | $441.50M derived: sum of 3 quarters · filed 2026-05-06 | $450.30M derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2025-12-31 | $8.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $17.20M derived: sum of 2 quarters · filed 2026-02-26 | $26.00M derived: sum of 3 quarters · filed 2026-08-05 | $34.80M 10-K · filed 2026-02-26 | ||
| 2025-09-27 | $8.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $17.30M derived: sum of 2 quarters · filed 2026-08-05 | $26.10M 10-Q · filed 2025-11-05 | $1.13B derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2025-06-28 | $8.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $17.60M 10-Q · filed 2026-08-05 | $1.13B derived: sum of 3 quarters · filed 2026-08-05 | $1.53B derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2025-03-29 | $8.80M 10-Q · filed 2026-05-06 | $1.12B derived: sum of 2 quarters · filed 2026-05-06 | $1.52B derived: sum of 3 quarters · filed 2026-05-06 | $1.53B derived: sum of 4 quarters · filed 2026-05-06 | ||
| 2024-12-31 | $1.11B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.51B derived: sum of 2 quarters · filed 2026-02-26 | $1.52B derived: sum of 3 quarters · filed 2026-02-26 | $1.53B 10-K · filed 2026-02-26 | ||
| 2024-09-28 | $400.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $410.60M derived: sum of 2 quarters · filed 2025-11-05 | $420.40M 10-Q · filed 2025-11-05 | $721.70M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-06-29 | $9.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $19.60M 10-Q · filed 2025-08-06 | $320.90M derived: sum of 3 quarters · filed 2026-02-26 | $330.00M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-03-30 | $9.80M 10-Q · filed 2025-05-07 | $311.10M derived: sum of 2 quarters · filed 2026-02-26 | $320.20M derived: sum of 3 quarters · filed 2026-02-26 | $329.20M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2023-12-31 | $301.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $310.40M derived: sum of 2 quarters · filed 2026-02-26 | $319.40M derived: sum of 3 quarters · filed 2026-02-26 | $325.30M 10-K · filed 2026-02-26 | ||
| 2023-09-30 | $9.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $18.10M derived: sum of 2 quarters · filed 2024-11-06 | $24.00M 10-Q · filed 2024-11-06 | $29.80M derived: sum of 4 quarters · filed 2025-02-28 | ||
| 2023-07-01 | $9.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $14.90M 10-Q · filed 2024-08-02 | $20.70M derived: sum of 3 quarters · filed 2025-02-28 | $26.60M derived: sum of 4 quarters · filed 2025-02-28 | ||
| 2023-04-01 | $5.90M 10-Q · filed 2024-05-07 | $11.70M derived: sum of 2 quarters · filed 2025-02-28 | $17.60M derived: sum of 3 quarters · filed 2025-02-28 | |||
| 2022-12-31 | $5.80M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $11.70M derived: sum of 2 quarters · filed 2025-02-28 | $970.60M 10-K · filed 2025-02-28 | $958.90M 10-K · filed 2023-02-28 | ||
| 2022-10-01 | $5.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $964.80M 10-Q · filed 2023-11-07 | $958.90M 10-Q · filed 2022-11-08 | |||
| 2022-07-02 | $958.90M 10-Q · filed 2023-08-08 | |||||
| 2021-12-31 | $30.60M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $30.60M derived: sum of 2 quarters · filed 2024-02-27 | $30.60M 10-K · filed 2024-02-27 | $0.00 10-K · filed 2022-03-01 | ||
| 2021-10-02 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $0.00 10-Q · filed 2022-11-08 | ||||
| 2021-07-03 | $0.00 10-Q · filed 2022-08-09 | |||||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $590.00M derived: sum of 2 quarters · filed 2023-02-28 | $590.00M derived: sum of 3 quarters · filed 2023-02-28 | $590.00M 10-K · filed 2023-02-28 | ||
| 2020-09-26 | $590.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $590.00M derived: sum of 2 quarters · filed 2021-11-12 | $590.00M 10-Q · filed 2021-11-12 | $590.00M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2020-06-27 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $0.00 10-Q · filed 2020-08-05 | $0.00 derived: sum of 3 quarters · filed 2022-03-01 | $317.10M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2020-03-28 | $0.00 10-Q · filed 2020-05-05 | $0.00 derived: sum of 2 quarters · filed 2022-03-01 | $317.10M derived: sum of 3 quarters · filed 2022-03-01 | $463.70M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $317.10M derived: sum of 2 quarters · filed 2022-03-01 | $463.70M derived: sum of 3 quarters · filed 2022-03-01 | $476.00M 10-K · filed 2022-03-01 | ||
| 2019-09-28 | $317.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $463.70M derived: sum of 2 quarters · filed 2020-11-05 | $476.00M 10-Q · filed 2020-11-05 | $488.50M derived: sum of 4 quarters · filed 2021-03-01 | ||
| 2019-06-29 | $146.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $158.90M 10-Q · filed 2020-08-05 | $171.40M derived: sum of 3 quarters · filed 2021-03-01 | $184.10M derived: sum of 4 quarters · filed 2021-03-01 | ||
| 2019-03-30 | $12.30M 10-Q · filed 2020-05-05 | $24.80M derived: sum of 2 quarters · filed 2021-03-01 | $37.50M derived: sum of 3 quarters · filed 2021-03-01 | $50.30M derived: sum of 4 quarters · filed 2021-03-01 | ||
| 2018-12-31 | $12.50M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $25.20M derived: sum of 2 quarters · filed 2021-03-01 | $38.00M derived: sum of 3 quarters · filed 2021-03-01 | $482.50M 10-K · filed 2021-03-01 | ||
| 2018-09-29 | $12.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $25.50M derived: sum of 2 quarters · filed 2019-11-06 | $470.00M 10-Q · filed 2019-11-06 | $837.30M derived: sum of 4 quarters · filed 2020-02-27 | ||
| 2018-06-30 | $12.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $457.30M 10-Q · filed 2019-08-08 | $824.60M derived: sum of 3 quarters · filed 2020-02-27 | $839.20M derived: sum of 4 quarters · filed 2020-02-27 | ||
| 2018-03-31 | $444.50M 10-Q · filed 2019-05-09 | $811.80M derived: sum of 2 quarters · filed 2020-02-27 | $826.40M derived: sum of 3 quarters · filed 2020-02-27 | $3.04B derived: sum of 4 quarters · filed 2020-02-27 | ||
| 2017-12-31 | $367.30M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $381.90M derived: sum of 2 quarters · filed 2020-02-27 | $2.60B derived: sum of 3 quarters · filed 2020-02-27 | $2.61B 10-K · filed 2020-02-27 | ||
| 2017-09-30 | $14.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $2.23B derived: sum of 2 quarters · filed 2018-11-08 | $2.24B 10-Q · filed 2018-11-08 | $2.26B derived: sum of 4 quarters · filed 2019-02-27 | ||
| 2017-07-01 | $2.22B derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $2.23B 10-Q · filed 2018-08-09 | $2.24B derived: sum of 3 quarters · filed 2019-02-27 | $2.76B derived: sum of 4 quarters · filed 2019-02-27 | ||
| 2017-04-01 | $13.60M 10-Q · filed 2018-05-08 | $27.00M derived: sum of 2 quarters · filed 2019-02-27 | $544.10M derived: sum of 3 quarters · filed 2019-02-27 | $558.50M derived: sum of 4 quarters · filed 2019-02-27 | ||
| 2016-12-31 | $13.40M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $530.50M derived: sum of 2 quarters · filed 2019-02-27 | $544.90M derived: sum of 3 quarters · filed 2019-02-27 | $559.20M 10-K · filed 2019-02-27 | ||
| 2016-10-01 | $517.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $531.50M derived: sum of 2 quarters · filed 2017-11-09 | $545.80M 10-Q · filed 2017-11-09 | $559.80M derived: sum of 4 quarters · filed 2018-03-01 | ||
| 2016-07-02 | $14.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | $28.70M 10-Q · filed 2017-08-10 | $42.70M derived: sum of 3 quarters · filed 2018-03-01 | $57.00M derived: sum of 4 quarters · filed 2018-03-01 | ||
| 2016-04-02 | $14.30M 10-Q · filed 2017-05-30 | $28.30M derived: sum of 2 quarters · filed 2018-03-01 | $42.60M derived: sum of 3 quarters · filed 2018-03-01 | $342.60M derived: sum of 4 quarters · filed 2018-03-01 | ||
| 2015-12-31 | $14.00M derived: 10-K 6 month − 10-Q 3 month · filed 2018-03-01 | $28.30M 10-K · filed 2018-03-01 | $328.30M derived: sum of 3 quarters · filed 2018-03-01 | $341.90M derived: sum of 4 quarters · filed 2018-03-01 | ||
| 2015-09-26 | $14.30M 10-Q · filed 2015-11-02 | $314.30M derived: sum of 2 quarters · filed 2017-05-22 | $903.30M 10-Q/A · filed 2017-05-23 | $1.22B derived: sum of 4 quarters · filed 2017-05-22 | ||
| 2015-06-27 | $300.00M 10-Q/A · filed 2017-05-22 | $889.00M 10-Q/A · filed 2017-05-22 | $1.21B derived: sum of 3 quarters · filed 2017-05-22 | $1.82B 10-K · filed 2018-03-01 | ||
| 2015-03-28 | $13.60M 10-Q/A · filed 2017-05-22 | $908.60M derived: sum of 2 quarters · filed 2017-05-22 | $948.20M 10-Q · filed 2015-04-29 | $983.10M derived: sum of 4 quarters · filed 2017-05-22 | ||
| 2014-12-27 | $895.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-05 | $934.50M 10-Q · filed 2015-02-05 | $969.50M derived: sum of 3 quarters · filed 2017-05-22 | $1.00B derived: sum of 4 quarters · filed 2017-05-22 | ||
| 2014-09-27 | $39.50M 10-Q · filed 2015-11-02 | $74.50M derived: sum of 2 quarters · filed 2017-05-22 | $109.50M derived: sum of 3 quarters · filed 2017-05-22 | $2.07B derived: sum of 4 quarters · filed 2017-05-22 | ||
| 2014-06-28 | $35.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-05-22 | $70.00M derived: sum of 2 quarters · filed 2017-05-22 | $2.04B derived: sum of 3 quarters · filed 2017-05-22 | $2.04B 10-K · filed 2017-05-22 | ||
| 2014-03-29 | $35.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-04-29 | $2.00B derived: sum of 2 quarters · filed 2015-04-29 | $2.00B 10-Q · filed 2015-04-29 | $2.00B derived: sum of 4 quarters · filed 2016-02-25 | ||
| 2013-12-28 | $1.97B derived: 10-Q 6 month − 8-K 3 month · filed 2015-02-05 | $1.97B 10-Q · filed 2015-02-05 | $1.97B derived: sum of 3 quarters · filed 2016-02-25 | $1.97B derived: sum of 4 quarters · filed 2016-02-25 | ||
| 2013-09-28 | $0.00 8-K · filed 2014-11-20 | $0.00 derived: sum of 2 quarters · filed 2016-02-25 | $0.00 derived: sum of 3 quarters · filed 2016-02-25 | |||
| 2013-06-29 | $0.00 derived: 10-KT 12 month − 10-Q 9 month · filed 2016-02-25 | $0.00 derived: sum of 2 quarters · filed 2016-02-25 | $40.00M 10-KT · filed 2016-02-25 | |||
| 2013-03-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-07 | $40.00M 10-Q · filed 2014-05-07 | ||||
| 2012-12-29 | $40.00M 10-Q · filed 2014-02-06 | |||||
| 2012-06-30 | $610.00M 10-K · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |